Telmisartan (Micardis)
Telmisartan lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.
$59.8M in CY2024 Part D spend2.0M claims · 667K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Telmisartan used for?
Telmisartan lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.
Is there a generic for Telmisartan?
Yes. 48 ANDAs filed at FDA, 16 generic manufacturers currently shipping.
How much does my plan pay for Telmisartan?
Across 329 Part D plans, Telmisartan averages $0.109/unit (NADAC). Lowest available: $0.107/unit. Highest in distribution: $0.149/unit.
Is Telmisartan on the FDA shortage list?
No. Telmisartan is not currently on the FDA Drug Shortage Database.
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.